Could virtual reality boost brain power in psychosis?
NCT ID NCT05973110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a virtual reality program designed to help people with psychosis improve their thinking and social skills. The program was created with input from patients and doctors. Researchers will see if it is practical and helpful for daily life. The study involves 52 adults aged 18 to 60 with a psychosis diagnosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 52 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of a psychosis-spectrum disorder * Equal or between 18 to 60 years old * Ability to read and speak English * Be clinically stable, as defined as a total Positive And Negative Severity Symptoms score equal or between 30 - 95 * No changes to their medication dosage, starting a new medication, or stopping a medication within the past month before signing the consent form Exclusion Criteria: * Neurological or medical disorders that may produce cognitive impairment (including head injury with more than 1 minute of loss of consciousness) * Intellectual disability or a score equal or below 70 on the Wechsler Abbreviated Scale of Intelligence. * Any vision conditions that cannot be corrected with contact lenses or glasses that can fit in the virtual reality googles. * Past history of seizures, fit, and epilepsy * Any severe medical condition related to the eyes, ears, and balance * History of substance use disorder within the last 3 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Psychotic disorders are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Royal Ottawa Mental Health Centre
RECRUITINGOttawa, Ontario, K1Z 7K4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug
- A shot every few weeks? new drug tested for schizophrenia